Adipose tissue dysfunction is an important cornerstone of MetS and T2DM by driving metabolic dysfunction, and is characterized by adipocyte hypertrophy, altered adipokine production (i.e., adiponectin and leptin) and lipid metabolism, and local inflammation [42,43,44]. This evidence concerns the gene LEP and metabolic syndrome.